|
a retrospective study to evaluate the efficacy and safety of polatuzumab vedotin provided as part of the compassionate use programme among malaysian patients with relapsed/refractory diffuse large b cell lymphoma
|
29-07-202130-06-2024
|
Penyelidik Bersama
|
|
a phase iii, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent b-cell non-hodgkin`s lymphoma (inhl) – chronos-3
|
15-12-201614-04-2021
|
Penyelidik Bersama
|
|
-
|
01-12-201630-11-2020
|
Ketua Projek
|
|
a multicenter, randomised, open-label, three-parallel groups, phase 2-3 study to evaluate the efficacy and safety of masitinib with dexamethasone, gemcitabine with dexamethasone and the combination of masitinib, gemcitabine and dexamethasone in patients w
|
29-09-201628-09-2020
|
Penyelidik Bersama
|
|
epidemiology of cutaneous graft versus host disease in allogeneic peripheral blood stem cell transplantation
|
16-05-201915-05-2020
|
Penyelidik Bersama
|
|
t-cell receptor repertoires as potential biomarkers in diagnosis, prognosis and treatment monitoring in diffuse large b-cell lymphoma patients.
|
15-08-201714-02-2020
|
Penyelidik Bersama
|
|
wound healing properties of autologous peripheral blood-derived mesenchymal stem cells, peripheral blood mononuclear cells and bone marrow mononuclear cells: a prospective, multicentre, randomized clinical trial.
|
01-01-201630-06-2019
|
Penyelidik Bersama
|